Take Solutions gains on planning to develop Unified AI Platform for healthcare ecosystem

Take Solutions Ltd. | IT - Software | IT & ITES | BSE: 532890 | NSE: TAKE

17 Feb 2026 Evaluate

Take Solutions is currently trading at Rs. 47.15, up by 0.61 points or 1.31% from its previous closing of Rs. 46.54 on the BSE.

The scrip opened at Rs. 46.29 and has touched a high and low of Rs. 48.60 and Rs. 44.31 respectively. So far 48596 shares were traded on the counter.

The BSE group 'T' stock of face value Rs. 1 has touched a 52 week high of Rs. 49.90 on 13-Feb-2026 and a 52 week low of Rs. 6.70 on 01-Apr-2025.

Last one week high and low of the scrip stood at Rs. 49.90 and Rs. 44.31 respectively. The current market cap of the company is Rs. 697.07 crore.

The Institutions and Non-Institutions held 0.56% and 99.44% stake in the company respectively.

Take Solutions has planned to develop a comprehensive Unified AI Platform. Designed to revolutionize the healthcare ecosystem, the platform serves as a one-stop digital infrastructure layer enabling hospitals, diagnostic laboratories, clinical trial organizations, and clinics to seamlessly adopt and deploy artificial intelligence solutions. This initiative marks a transformational step in the company’s evolution, deeply aligned with the Government of India’s push to position AI as a critical development tool for societal good.

The platform supports the national mandate for affordable, accessible care by significantly reducing technology adoption barriers, implementation complexity, and upfront investment requirements. It is designed to support multiple healthcare use cases critical to public and private health, including -- Diagnostics & pathology automation, Clinical decision support systems, Hospital workflow & operational automation, Clinical trial optimization & patient data intelligence & Preventive healthcare and proactive care scaling.

Healthcare providers are rapidly increasing technology spending to improve clinical outcomes, creating a massive opportunity for platforms that can deliver scalable, real-world impact. By offering an integrated AI marketplace, the company aims to onboard a large base of healthcare providers, generating scalable revenues while directly supporting the nation's broader socioeconomic goals of inclusive growth and technological self-reliance under the IndiaAI Mission.

Take Solutions delivers domain-intensive services in Life Sciences and Supply Chain Management.

Take Solutions Share Price

31.25 -1.64 (-4.99%)

11-May-2026 16:59 View Price Chart

Peers

Company Name	CMP
TCS	2392.45
Infosys	1176.80
HCL Tech.	1194.95
Wipro	196.60
Tech Mahindra	1457.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.